Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.65    -0.02 (-0.75%)
Bid:
2.64
Ask:
2.65
Spread: 0.01 (0.379%)
Market Cap: $8.74b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

3rd Quarter 2022 Results (Separate)

4 Nov 2022 07:00

RNS Number : 2910F
Commercial Intnl Bank (Egypt) SAE
04 November 2022
Β 

Β 

Β 

Commercial International Bank (Egypt) S.A.E.

Condensed Separate Financial Statements

September 30, 2022

Click on, or paste the following link into your web browser, to view the associated PDF document

http://www.rns-pdf.londonstockexchange.com/rns/2910F_1-2022-11-3.pdf

Β 

Β 

Condensed Separate Interim Statement of Financial Position as atΒ September 30, 2022

Β 

Β 

Notes

Sep. 30, 2022

Β 

Dec. 31, 2021

Β 

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Β 

Β 

Β 

Β 

Assets

Β 

Β 

Β 

Β 

Cash and balances at the central bank

8

43,776,754

Β 

43,385,222

Β 

Due from banks

9

90,378,194

Β 

79,991,287

Β 

Loans and advances to banks, net

11

1,944,633

Β 

312,216

Β 

Loans and advances to customers, net

12

176,669,649

Β 

144,765,808

Β 

Derivative financial instruments

Β 

951,214

Β 

225,376

Β 

Investments

Β 

Β 

Β 

- Financial Assets at Fair Value through P&L

13

-

Β 

240,987

Β 

- Financial Assets at Fair Value through OCI

13

230,060,807

Β 

192,390,931

Β 

- Financial Assets at Amortized cost

13

32,306,835

Β 

20,318,767

Β 

- Investments in associates and subsidiaries

14

1,074,250

Β 

1,014,350

Β 

Other assets

15

10,167,659

Β 

11,141,917

Β 

Deferred tax assets (Liabilities)

Β 

727,276

Β 

460,026

Β 

Property and equipment

16

2,302,530

Β 

2,404,237

Β 

Total assets

Β 

590,359,801

Β 

496,651,124

Β 

Liabilities and equity

Β 

Β 

Β 

Liabilities

Β 

Β 

Β 

Due to banks

17

1,703,884

Β 

862,759

Β 

Due to customers

18

497,584,590

Β 

406,100,916

Β 

Derivative financial instruments

Β 

43,987

Β 

265,265

Β 

Current income tax liabilities

2,678,372

Β 

2,234,985

Β 

Other liabilities

19

9,945,543

Β 

8,021,310

Β 

Issued debt instruments

20

1,940,240

Β 

1,557,263

Β 

Other loans

Β 

6,257,126

Β 

5,140,782

Β 

Other Provisions

21

5,675,006

Β 

3,539,676

Β 

Total liabilities

Β 

525,828,748

Β 

427,722,956

Β 

Equity

Β 

Β 

Β 

Β 

Issued and paid up capital

26

29,825,134

Β 

19,702,418

Β 

Reserves

20,381,196

Β 

33,767,423

Β 

Reserve for employee stock ownership plan (ESOP)

Β 

1,751,123

Β 

1,674,392

Β 

Retained earnings *

Β 

12,573,600

Β 

13,783,935

Β 

Total equity and net profit for the period / year

Β 

64,531,053

Β 

68,928,168

Β 

Total liabilities and equity

Β 

590,359,801

Β 

496,651,124

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

The accompanying notes are an integral part of these financial statements.

Β 

Β 

Β 

(Review report attached)

Β 

Β 

*Including net profit for the current period

Β 

Β 

Β 

Β 

Β 

Β 

Hussein Abaza

Sherif Samy

Β 

CEO & Managing Director

Chairman

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Separate Interim Income Statement for the period ended September 30, 2022

Β 

Β 

Β 

Β 

Β 

Β 

Last 9 Months

Last 9 Months

Β 

Β 

Notes

Β 

Sep. 30, 2022

Β 

Sep. 30, 2021

Β 

Β 

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Β 

Β 

Β 

Β 

Interest and similar income

38,761,627

Β 

32,568,923

Β 

Interest and similar expense

(17,050,977)

Β 

(14,463,322)

Β 

Net interest income

21,710,650

Β 

18,105,601

Β 

Β 

Β 

Β 

Β 

Fee and commission income

3,900,488

Β 

2,895,435

Β 

Fee and commission expense

(1,730,066)

Β 

(1,129,866)

Β 

Net fee and commission income

2,170,422

Β 

1,765,569

Β 

Β 

Β 

Β 

Β 

Dividends income

Β 

64,372

Β 

82,426

Β 

Net trading income

5

Β 

1,431,729

Β 

484,774

Β 

Profits (Losses) on financial investments

13

Β 

1,096,850

Β 

634,108

Β 

Administrative expenses

Β 

(5,024,897)

Β 

(4,382,463)

Β 

Other operating (expenses) income

6

(3,399,057)

Β 

(1,366,178)

Β 

Impairment release (charges) for credit losses

Β 

Β 

(262,606)

Β 

(1,325,770)

Β 

Profit before income tax

Β 

17,787,463

Β 

13,998,067

Β 

Β 

Β 

Β 

Β 

Income tax expense

25

(4,984,283)

Β 

(4,115,227)

Β 

Deferred tax assets (Liabilities)

25

(597,258)

Β 

11,845

Β 

Net profit for the period

Β 

12,205,922

Β 

9,894,685

Β 

Β 

Β 

Β 

Β 

Earning per share

7

Β 

Β 

Β 

Basic

3.62

Β 

2.97

Β 

Diluted

3.60

Β 

2.95

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Hussein Abaza

CEO & Managing Director

Β 

Sherif Samy

Β 

Chairman

Β 

Β 

Β 

Β 

Β 

Condensed Separate Interim Statement of Comprehensive Income for the period ended September 30, 2022

Β 

Β 

Β 

Β 

Β 

Last 9 Months

Β 

Last 9 Months

Β 

Sep. 30, 2022

Β 

Sep. 30, 2021

Β 

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Β 

Β 

Β 

Β 

Net profit for the period

12,205,922

Β 

9,894,685

Β 

Β 

Β 

Β 

Change in fair value of financial instruments measured at fair value through other comprehensive income after income tax

(13,128,801)

Β 

(2,374,495)

Β 

Transferred to RE from financial assets at fair value through OCI

(4,128)

Β 

(177,362)

Β 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

233,717

Β 

(98,246)

Β 

Total comprehensive income for the period

(693,290)

Β 

7,244,582

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Separate Interim Cash Flows for the period ended September 30, 2022

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Notes

Sep. 30, 2022

Β 

Sep. 30, 2021

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Cash flow from operating activities

Β 

Β 

Profit before income tax

17,787,463

Β 

13,998,067

Adjustments to reconcile profits to net cash provided by operating activities

Β 

Β 

Fixed assets depreciation

Β 

16

654,220

Β 

636,413

Impairment charge for credit losses (Loans and advances to customers and banks)

Β 

Β 

(16,255)

Β 

1,385,835

Other provisions charges

Β 

21

1,803,863

Β 

190,858

Impairment charge for credit losses (due from banks)

Β 

Β 

849

Β 

38,181

Impairment (Released) charge for credit losses (financial investments)

278,012

Β 

(98,246)

Impairment (Released) charge for other assets

(277,768)

Β 

31,975

Exchange revaluation differences for financial assets at fair value through OCI and AC

(3,745,045)

Β 

40,050

Utilization of other provisions

21

(1,857)

Β 

(44,978)

Other provisions no longer used

Β 

21

(101)

Β 

(12,255)

Exchange differences of other provisions

Β 

21

333,425

Β 

(13,722)

Losses (profits) from selling property and equipment

Β 

Β 

(2,192)

Β 

(2,124)

Losses (profits) from selling financial investments at fair value through OCI

Β 

13

(1,096,850)

Β 

(643,467)

Shares based payments

Β 

Β 

579,653

Β 

477,644

Impairment (Released) charges of investments in associates

Β 

Β 

-

Β 

9,359

Operating profits before changes in operating assets and liabilities

16,297,417

Β 

15,993,590

Β 

Β 

Β 

Net decrease (increase) in assets and liabilities

Β 

Β 

Due from banks

845,633

Β 

(272,238)

Financial assets at fair value through P&L

13

240,987

Β 

153,260

Derivative financial instruments

Β 

Β 

(947,116)

Β 

(24,448)

Loans and advances to banks and customers

Β 

11 - 12

(33,520,003)

Β 

(20,847,787)

Other assets

Β 

Β 

1,242,254

Β 

(1,631,518)

Due to banks

Β 

17

841,125

Β 

(7,272,811)

Due to customers

Β 

18

91,483,674

Β 

62,999,029

Current income tax obligations paid

Β 

Β 

(2,305,911)

Β 

(2,152,739)

Other liabilities

Β 

Β 

(310,752)

Β 

1,414,946

Net cash used in (generated from) operating activities

Β 

Β 

73,867,308

Β 

48,359,284

Β 

Β 

Β 

Β 

Β 

Cash flow from investing activities

Β 

Β 

Payments for investment in subsidiaries and associates.

(59,900)

Β 

(158,360)

Payment for purchases of property, equipment and branches constructions

(542,743)

Β 

(669,801)

Proceeds from selling property and equipment

2,192

Β 

2,124

Proceeds from redemption of financial assets at amortized cost

6,569,803

Β 

4,725,376

Payment for purchases of financial assets at amortized cost

(18,239,332)

Β 

(3,844)

Payment for purchases of financial assets at fair value through OCI

(114,918,927)

Β 

(207,918,546)

Proceeds from selling financial assets at fair value through OCI

73,463,225

Β 

146,303,855

Net cash generated from (used in) investing activities

(53,725,682)

Β 

(57,719,196)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Separate Interim Cash Flows for the period ended September 30, 2022 (Cont.)

Β 

Β 

Sep. 30, 2022

Β 

Sep. 30, 2021

Β 

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Β 

Β 

Cash flow from financing activities

Β 

Β 

Β 

Other loans

1,116,344

Β 

(2,113,845)

Β 

Dividends paid

(4,410,322)

Β 

(1,360,652)

Β 

Issued debt instruments

382,977

Β 

1,556,032

Β 

Capital increase

122,716

Β 

-

Β 

Net cash generated from (used in) financing activities

(2,788,285)

Β 

(1,918,465)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net (decrease) increase in cash and cash equivalent during the period

17,353,341

Β 

(11,278,377)

Β 

Beginning balance of cash and cash equivalent

60,891,899

Β 

75,965,247

Β 

Cash and cash equivalent at the end of the period

78,245,240

Β 

64,686,870

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalent comprise:

Β 

Β 

Β 

Cash and balances at the central bank

43,776,754

Β 

33,207,606

Β 

Due from banks

90,419,482

Β 

72,015,406

Β 

Treasury bills and other governmental notes

10

87,119,766

Β 

65,654,913

Β 

Obligatory reserve balance with CBE

Β 

(38,022,832)

Β 

(27,183,002)

Β 

Due from banks with maturities more than three months

(22,949,758)

Β 

(16,980,376)

Β 

Treasury bills with maturity more than three months

(82,098,172)

Β 

(62,027,677)

Β 

Total cash and cash equivalent

78,245,240

Β 

64,686,870

Β 

'

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended September 30, 2021

Β 

Β 

Sep. 30, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

EGP Thousands

Beginning balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626

Capital increase

4,925,605

-

(4,925,605)

-

-

-

-

-

-

-

Transferred to reserves

-

514,939

8,420,479

-

1,094

-

-

(8,936,512)

-

-

Dividend paid

-

-

-

-

-

-

-

(1,360,652)

-

(1,360,652)

Net profit of the period

-

-

-

-

-

-

-

9,894,685

-

9,894,685

Transferred from reserve of financial assets at fair value through OCI

-

-

-

-

-

(177,362)

-

177,362

-

-

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

8,333

-

8,333

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(2,374,495)

-

-

-

(2,374,495)

Transferred (from) to bank risk reserve

-

-

-

-

-

-

2,718

(2,718)

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

(98,246)

-

-

-

(98,246)

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

477,644

477,644

Ending balance

19,702,418

3,293,074

28,260,532

1,549,445

16,000

1,320,884

9,141

10,258,109

1,542,292

65,951,895

Condensed Separate Interim statement of changes in shareholders' equity for the period ended September 30, 2022

Β 

Β 

Β 

Β 

Sep. 30, 2022

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

Β 

Β 

Β 

Β 

Β 

EGP Thousands

Β 

Beginning balance

19,702,418

3,293,074

28,260,532

1,549,445

16,000

639,231

9,141

13,783,935

1,674,392

68,928,168

Β 

Β 

Β 

Β 

Capital increase

10,122,716

-

(10,000,000)

-

-

-

-

-

-

122,716

Β 

Β 

Β 

Β 

Transferred to reserves

-

670,872

8,836,326

-

2,947

-

-

(9,007,223)

(502,922)

-

Β 

Β 

Β 

Β 

Dividend paid

-

-

-

-

-

-

-

(4,410,322)

-

(4,410,322)

Β 

Β 

Β 

Β 

Net profit of the period

-

-

-

-

-

-

-

12,205,922

-

12,205,922

Β 

Β 

Β 

Β 

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

(4,128)

-

4,128

-

-

Β 

Β 

Β 

Β 

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

-

-

-

Β 

Β 

Β 

Β 

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(13,128,801)

-

-

-

(13,128,801)

Β 

Β 

Β 

Β 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,840

(2,840)

-

-

Β 

Β 

Β 

Β 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

233,717

-

-

-

233,717

Β 

Β 

Β 

Β 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

579,653

579,653

Β 

Β 

Β 

Β 

Ending balance

29,825,134

3,963,946

27,096,858

1,549,445

18,947

(12,259,981)

11,981

12,573,600

1,751,123

64,531,053

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
QRTFLFSALELVIIF
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.